Products

Cancer-derived iPSc

 

 

Celther Polska offers iPS cells generated from cells obtained from patients with prostate or breast cancer.

CLTH/iPSc-breast-cancer and CLTH/iPSc-prostate-cancer were established through reprogramming of

cells derived from patients diagnosed with prostate or breast cancer.

These cells display pluripotency markers (TRA-1-60, TRA-1-81, NANOG, alkaline phosphatase activity).

 

 

There are two types.

• CLTH/iPSc-breast cancer

• CLTH/iPSc-prostate cancer

    

   

Form:		Frozen
Species:		Human
Culture type:		Adherent Cell Culture
Donor source:		Single donor
Number of cells:		30 colonies
Tests Performed:		Sterility Testing (Bacteria & Fungi)

  

 

Ordering information;

    

Catalog No.	Product Name	Size
CL 05018-BC-CLTH	CLTH/iPSc-breast cancer	1 vial
CL 05018-PC-CLTH	CLTH/iPSc-prostate cancer	1 vial